Cognitive evaluation of patients with chronic neurolathyrism

Parkinsonism and Related Disorders

Volumn 5, Issue 1-2, 1999, Pages 55-58

  Paleacu, D ^a,b   Cohn, D F ^a,b   Rabey, J M ^b,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Beta N oxaloamino L alamine (BOAA); Lathyrus Sativus; Neurolathyrism

Indexed keywords

AGED; ARTICLE; CELL INCLUSION; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LATHYRISM; MALE; MOTONEURON; NERVE CELL DEGENERATION; PARAPLEGIA; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRAMIDAL TRACT; SPASTIC PARAPLEGIA; SPINE;

EID: 0033021354     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(99)00016-4     Document Type: Article

References (21)

1. Ganapathy KT, Dwivedi MP. Studies on clinical epidemiology of lathyrism. Rewa (MP), India: Lathyrism Enquiry Field Unit, 1961. p. 29.
2. Cohn D.F., Streifler M. Human neurolathyrism: a follow-up study of 200 patients; part 1: clinical investigation. Arch Suisses de Neurol, Neurochirur et de Psychiat. 128:1981;151-156.
3. Calne D.B. Lathyrism and Lytigo-Bodig disease. Am Acad Neurol Cour. 346:1991;55-61.
4. Littre F. Hippocrates, on epidemics. 5:1986;126. Book 2, Section 4.
5. Denny-Brown D. Neurological conditions resulting from prolonged and severe dietary restriction. Medicine. 26:1947;41-113.
6. Cohn D.F., Streifler M. Neurolathyrism: historical notes. Koroth. 7:1978;147-152.
7. Kessler A. Lathyrismus. Monatschr. Psychiatr. u Neurol. 113: 345-76.
8. Roy D.N., Spencer P.S., Nunn P.B. Toxic components of lathyrus. Kau A.K., Combes D. Lathyrus and lathyrism, Proceedings of Colloque Lathyrus. 1985;287-296 Singapore National Printers, Singapore.
9. Spencer P.S. Guam ALS/parkinsonism-dementia: A long neurotoxic caused by slow toxin(s) in food? Can J Neurol Sci. 14:1987;347-357.
10. Kurland L.T. An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam. Fed Proc. 31:1972;1540-1542.
11. Steele J.C., Guzman T. Observations about amyotrophic lateral sclerosis and the Parkinson-dementia complex of Guam with regard to epidemiology and etiology. Can J Neurol Sci. 14:1987;358-362.
12. Strub R.L., Black F.W. The mental status examination in neurology. 1985;Davis Company, Philadelphia, PA.
13. Diagnostic and statistical manual of mental disorder. Fourth ed. DSM-IV, American Psychiatric Association, Washington DC, 1994.
14. Wechsler D. A standardized memory scale for clinical use. J Psychol. 19:1945;87-95.
15. Spencer P.S., Schaumburg H.H., Cohn D.F., Seth P.K. Lathyrism: a useful model of primary lateral sclerosis. Rose F.C. Research progress in motor neurone disease. 1984;312-317 Pitman, Bath.
16. Hirano A., Llena J.F., Streifler M., Cohn D.F. Anterior horn cell changes in a case of neurolathyrism. Acta Neuropath (Berlin). 35:1976;277-283.
17. Streifler M., Cohn D.F., Hirano A., Schujman E. The central nervous system in a case of neurolathyrism. Neurology (Minneapolis). 37:1977;1176-1178.
18. Olney J.W., Misra C.H., Rhee V. Brain and retinal damage from lathyrus excitotoxin-N-oxalyl-L-diaminopropionic acid. Nature (London). 264:1976;659-661.
19. Vega A., Bell E.A. Alpha-amino-betametylaminoproprionic acid: A new aminoacid from seeds of cycas circinalis. Phytochemistry. 6:1967;759-762.
20. Spencer P.S., Nunn P.B., Hugon J., et al. Motor neurone disease on Guam: Possible role of a food neurotoxin. Lancet. 1:1986;965.
21. Pai K.S., Shankar S.K., Ravindranath V. Billion fold difference in the toxic potencies of two excitatory plant aminoacids L-BOAA and L-BMAA: biochemical and morphological studies using mouse brain slices. Neurosci Res. 17:1993;241-248.